Cannabis Science Provides Update on Its “Trimcare

New Post Public Reply Private Reply Replies (0) Message Board

Jun 21, 2012 at 10:35 AM

Cannabis Science Provides Update on Its “Trimcare Brand” Acquisition
Print
Alert
Cannabis Science (OTCBB:CBIS)
Intraday Stock Chart
Today : Thursday 21 June 2012

Cannabis Science, Inc. (CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis-based products, is pleased to provide an update on its recent acquisition of the “Trimcare Brand”. Cannabis previously announced the acquisition on June 11, 2012.

Since that time, while further reviewing the agreements, both parties realized that due to some legal issues regarding licensing and ownership of certain assets the agreements need to be re-drafted.

The parties are currently working with the attorney’s on revising the finalized documents and once the documents are finalized, Cannabis will make its filings with the S.E.C. disclosing the acquisition.

Dr. Ivan Goldsmith has provided 20 years of professional service within the Las Vegas community. Trimcare has 5,000 active patients consisting of in and out of state patients, who are being treated by internal medicine, bariatrics, and anti-aging methods. Trimcare is a premier integrated weight loss and anti-aging clinic in Las Vegas. Also providing a number of additional services such as a “Physician Dispensing Pharmacy”. Cannabis Science comes together with Goldsmith Heath Care, in plans to expand the Trimcare line across the US in every major metropolis. These plans consist of opening up a second, third and fourth location in Las Vegas. Cannabis Science is currently in negotiations to open up the second clinic, in Henderson, Las Vegas. The first clinic already resides at 4240 West Flamingo Rd in Las Vegas and is 5,000 square feet.

Dr. Ivan Goldsmith and his staff will continue to work with Cannabis Science immensely. In addition to expanding operations, the Companies will combine their formulations along with medical cannabis to bring together a new line of products, ranging from all areas of medical and cosmetic needs. Trimcare is active in alternative delivery methods such as creams, pellets, patches, and transdermal skin delivery systems. Trimcare currently has 30 over-the-counter products on the market. Making up these product lines are supplements, skin care products, food, and hormone products. From inception, manufacturing, commercialization, relationships and products, Dr. Goldsmith has brought these 30 products to the market himself, and Cannabis Science plans to use his expertise and integrate them into its future line of products as well.

Cannabis Science will add many new additions to its team within its Executive Management, Scientific Advisory Board and Policy Advisory Board, including Trimcare employees, will have almost 30 staff members ranging from a wide variety of expertise.

For further information about Trimcare and Dr. Ivan Goldsmith, you can go to the Trimcare website, www.trimcare.com or read the previous news release on the Cannabis Science website www.cannabisscience.com, dated May 3, 2012 or click this link, http://www.cannabisscience.com/news-a-media/p...ystem.html.

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

Forward Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Indico Breach May Expose Thousands to Identity Theft

Data Breach Unsettles Indico's Operations Well, this is the kind of headache nobody wants on their spreadsheet—the unpleasant fallout from a significant data breach is rocking Indico Data Solutions. When you hear words like 'unauthorized party' and 'exposed sensitive personal information,' it ought to make investors sit up and pay attention. On May 7, 2026, Indico, the...

Zepp Health's Q2 2026 Results: Growth Amid Struggles

Revenue Growth, Yet the Road Is Rocky Buckle up, investors, because Zepp Health Corporation's (NYSE: ZEPP) latest financials are a bit of a mixed salad—there's some good and some bad tossed in. Reporting a revenue of $63.5 million for the second quarter of 2026, the company managed to eke out a 6.9% increase year-over-year. But before you pop the champagne, let's dig a...

Acer's New Monitors: ePaper, Triple Displays & More

Next-Gen Screens: Breakthrough or Bust? So, Acer’s stepping up its game, unveiling an armory of gadgets designed to cement their spot in the tech arena. On the menu today? ePaper displays and enhanced connectivity gizmos that could either tip the scales or sink like a stone. Keep your eyes peeled, though—these updates aren't just another throwaway press release....

BOC Group's Challenger Role Eye-Opener in Gartner Quadrant

Cracking the Challenger Code: BOC Group's Debut Ever heard of BOC Group? If you haven’t, it’s time to pay attention. This Dublin-based outfit just muscled its way into the Challenger Quadrant of the 2026 Gartner Magic Quadrant for Digital Twin of an Organization Platforms. Not bad for its first trip to the dance. When a company crashes the scene like this, eyebrows...

Ivonescimab Shows Strong Survival in Key Lung Cancer Trial

New Frontiers in Lung Cancer Treatment Well, here's a story that rattles the cage in the oncology world. The name of the game is ivonescimab, Akeso’s latest move as they toss their hat into the already crowded yet pivotal lung cancer treatment ring. This isn't just some side hustle—they've got Phase III data pointin' straight north, figuratively casting a shadow over...

Volato Group Faces Merger Scrutiny Amid SOAR Deal

Unraveling the Volato Merger Drama Boy, the plot thickens with Volato Group, Inc. (SOAR), and it ain’t the first time we’ve seen this kind of shuffle in the market. Now, Volato’s got itself tangled up with Alignment Engine Inc. through a proposed merger. Sounds routine at first; we all know mergers are part of the corporate game. But here's the twist—shareholders...

Kareem's Lebanese Kitchen: A Culinary Tribute to Maryland

Embracing Tradition with a Modern Twist Well, here's to new beginnings wrapped in old flavors, folks. September 1, 2026, marks the arrival of Kareem's Lebanese Kitchen at Rio Lakefront in Gaithersburg, Maryland. It's where the Mediterranean meets the Chesapeake in an unexpected culinary celebration. Chef Rachid Eido's Legacy Third-generation Lebanese Chef Rachid Eido is...

RealityMine Appoints CPO Amidst Strong Growth Momentum

Pushing the Boundaries of Behavioral Data When a company like RealityMine posts a whopping 75% year-over-year revenue bump, you know they're not here to mess around. Enter Soumya Bijjal, a seasoned pro stepping in as their inaugural Chief Product Officer. This isn't just about adding to the C-suite boys' club; it's about locking in on a goldmine of behavioral data that's...

Kroger's Strategic Shift: Ibbotson's Bold New Charge

Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...

Innventure Faces Class Action Over Alleged Deception

Unpacking the Innventure Debacle Innventure, Inc. (NASDAQ:INV) seems to have landed itself in hot water, and not the relaxing kind. The revelation that its grand AI data center project in Ontario might never have existed has stirred up quite a storm among shareholders. This isn't just some run-of-the-mill oversight. We're talking about allegations of concocted stories...